Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma
- 23 April 2002
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 51 (5) , 625-630
Abstract
Paraneoplastic chorea is described in 16 patients: 11 with limited small‐cell carcinoma, 2 with lung cancer revealed by imaging, 1 with renal cell carcinoma, and 1 with lymphoma. All had CRMP‐5‐IgG; 6 also had ANNA‐1 (anti‐Hu), including 1 without evident cancer. Chorea was the initial and most prominent symptom in 11 patients, asymmetric or unilateral in 5 patients, and part of a multifocal syndrome in 14 patients. Basal ganglia abnormalities were revealed by magnetic resonance imaging and at autopsy (as perivascular inflammation and microglial activation). Four patients improved with chemotherapy, and 2 improved with intravenous methylprednisolone.Keywords
This publication has 20 references indexed in Scilit:
- Response to cancer therapy in a patient with a paraneoplastic choreiform disorderNeurology, 2001
- Ballistic-Choreic Movements as the Presenting Feature of Renal CancerArchives of Neurology, 2001
- CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunityAnnals of Neurology, 2001
- Chorea resulting from paraneoplastic striatal encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Paraneoplastic choreic syndrome during non-Hodgkin's lymphomaMovement Disorders, 2000
- Chorea as a paraneoplastic complication of Hodgkin's diseaseJournal of Neuro-Oncology, 1998
- Chorea in the Antiphospholipid Syndrome: Clinical, Radiologic, and Immunologic Characteristics of 50 Patients from Our Clinics and the Recent LiteratureMedicine, 1997
- Chorea resulting from paraneoplastic encephalitisMovement Disorders, 1997
- Guidelines for the Diagnosis of Rheumatic FeverJAMA, 1992
- Chorea and dystonia: A remote effect of carcinomaMovement Disorders, 1988